Gene Selection in Cancer Classification using GPSO/SVM and GA/SVM Hybrid Algorithms by Alba, Enrique et al.
Gene Selection in Cancer Classification using
GPSO/SVM and GA/SVM Hybrid Algorithms
Enrique Alba, Jose´ Garcia-Nieto, Laetitia Jourdan, El-Ghazali Talbi
To cite this version:
Enrique Alba, Jose´ Garcia-Nieto, Laetitia Jourdan, El-Ghazali Talbi. Gene Selection in Cancer
Classification using GPSO/SVM and GA/SVM Hybrid Algorithms. Congress on Evolutionary
Computation, Sep 2007, Singapor, Singapore. IEEE, 2007. <inria-00269967>
HAL Id: inria-00269967
https://hal.inria.fr/inria-00269967
Submitted on 3 Apr 2008
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.
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GA/SVM Hybrid Algorithms
Enrique Alba, Jose´ Garcı´a-Nieto, Laetitia Jourdan and El-Ghazali Talbi
Abstract— In this work we compare the use of a Particle
Swarm Optimization (PSO) and a Genetic Algorithm (GA)
(both augmented with Support Vector Machines SVM) for
the classification of high dimensional Microarray Data. Both
algorithms are used for finding small samples of informative
genes amongst thousands of them. A SVM classifier with 10-
fold cross-validation is applied in order to validate and evaluate
the provided solutions. A first contribution is to prove that
PSOSVM is able to find interesting genes and to provide clas-
sification competitive performance. Specifically, a new version
of PSO, called Geometric PSO, is empirically evaluated for
the first time in this work using a binary representation in
Hamming space. In this sense, a comparison of this approach
with a new GASVM and also with other existing methods of
literature is provided. A second important contribution consists
in the actual discovery of new and challenging results on six
public datasets identifying significant in the development of a
variety of cancers (leukemia, breast, colon, ovarian, prostate,
and lung).
I. INTRODUCTION
Microarray technology (DNA microarray) [1] allows to
simultaneously analyze thousands of genes and thus can give
important insights about cell’s function, since changes in
the physiology of an organism are generally associated with
changes in gene expression patterns. Several gene expres-
sion profiles obtained from tumors such as Leukemia [2],
Colon [3] and Breast [4] have been studied and compared to
expression profiles of normal tissues. However, expression
data are highly redundant and noisy, and most genes are
believed to be uninformative with respect to studied classes,
as only a fraction of genes may present distinct profiles for
different classes of samples. So, tools to deal with these
issues are critically important. These tools should learn to
robustly identify a subset of informative genes embedded
out of a large dataset which is contaminated with high-
dimensional noise [5].
In this context, feature selection is often considered as
a necessary preprocess step to analyze these data, as this
method can reduce the dimensionality of the datasets and
often conducts to better analyses [6].
Two models of feature selection exist depending on
whether the selection is coupled with a learning scheme or
not. The first one, filter model, which carries out the feature
subset selection and the classification in two separate phases,
uses a measure that is simple and fast to compute. Hence,
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a filter method, is in definition, independent of the learning
algorithm used after it. The second one, the wrapper method,
which carries out the feature subset selection and classifi-
cation in the same process, engages a learning algorithm
to measure the classification accuracy. From a conceptual
point of view, wrapper approaches are clearly advantageous,
since the features are selected by optimizing the discriminate
power of the finally used induction algorithm.
Feature selection for gene expression analysis in cancer
prediction often uses wrapper classification methods [7] to
discriminate a type of tumor, to reduce the number of genes
to investigate in case of a new patient, and also to assist
in drug discovery and early diagnosis. Several classification
algorithms could be used for wrapper methods, such as K-
Nearest Neighbor (K-NN) [8] or Support Vector Machines
(SVM) [9]. By creating clusters a big reduction of the number
of considered genes and an improvement of the classification
accuracy can be finally achieved.
The definition of the feature selection problem is this:
given a set of features F = {f1, ..., fi, ..., fn}, find a subset
F ′ ⊆ F that maximizes a scoring function Θ : Γ → G such
that
F ′ = argmaxG⊂Γ{Θ(G)}, (1)
where Γ is the space of all possible feature subsets of
F and G a subset of Γ. The optimal feature selection
problem has been shown to be NP-hard [10]. Therefore,
only heuristics approaches are able to deal with large size
problems. Recently, such advanced structured methods have
been used to explore the huge space of feature subsets, like
for example metaheuristics as Evolutionary Algorithms and,
specifically, Genetic Algorithms (GAs) [11], [5], [12].
In this work, we are interested in gene selection and
classification of DNA Microarray data in order to distin-
guish tumor samples from normal ones. For this purpose,
we propose two hybrid models that use metaheuristics and
classification techniques. The first one consists of a Particle
Swarm Optimization (PSO) [13] combined with a SVM
approach. PSO is a population based metaheuristic inspired
by the social behavior of bird flocking or fish schooling.
Specifically, a recent version called Geometric PSO [14]
(explained in Section II) has been used in this work. The
second model is based on the popular GA using a spe-
cialized Size-Oriented Common Feature Crossover Operator
(SSOCF) [15], which keeps useful informative blocks and
produces offsprings which have the same distribution than
the parents. This model will be also combined with SVM in
our approach.
Both proposed approaches are experimentally assessed on
six well-known cancer datasets (Leukemia, Colon, Breast,
Ovarian [16], Prostate [17] and Lung [18]), discovering new
and challenging results and identifying specific genes that
our work suggests as significants. Performances of proposed
PSO and GA algorithms solving the gene extraction problem
(using SVM) are compared in this paper. Specifically, we fo-
cused in the capacity of the PSOSVM combination in order
to provide considerable performance in this matter. In this
sense, comparisons with several state of art methods show
competitive results according to the conventional criteria.
The outline of this work as follows. We review the PSO
and the SVM techniques in order to introduce our PSOSVM
hybrid model in Section II. In Section III, the six microarray
datasets used in this study are described. Experimental results
are presented in Section IV, including biological descriptions
of several obtained genes. Finally, we summarize our work
and present some conclusions and possible future work in
Section V.
II. GENE SELECTION AND CLASSIFICATION BY
PSOSVM
In this section, we describe the hybrid PSOSVM approach
for gene selection and classification of Microarray data. The
PSO algorithm is designed for obtaining gene subsets as
solutions in order to reduce the high number of genes to
be later classified. The SVM classifier is used whenever the
fitness evaluation of a tentative gene subset is required.
A. Particle Swarm Optimization
Particle Swarm Optimization was first proposed by
Kennedy and Eberhart in 1995 [13]. PSO is a population
based evolutionary algorithm inspired in the social behavior
of bird flocking or fish schooling. In the description of PSO,
the swarm is made up of a certain number of particles (sim-
ilar to population of individuals in EAs). At each iteration,
all the particles move in the problem space to find the global
optima. Each particle has a current position vector and a
velocity vector for directing its movement.
vk+1i = ω · vki +ϕ1 · rnd1 · (pBesti− xki )+ϕ2 · rnd2 · (gi− xki ) (2)
xk+1i = x
k
i + v
k+1
i (3)
Equations 2 and 3 describe the velocity and position update
of a given particle i at a certain iteration k. Equation 2
calculates a new velocity vi for each particle (potential
solution) based on its previous velocity, the particle’s location
at which the best fitness so far has been found pBesti,
and the population global (or local neighborhood, in the
neighborhood version of the algorithm) location at which
the best fitness so far has been achieved gi. Individual and
social weight are represented by means of ϕ1 and ϕ2 factors
respectively. Finally, rnd1 and rnd2 are random numbers
in range {0, 1}, and ω represents the inertia weight factor.
Equation 3 updates each particle’s position xi in solution
space.
B. The SVM Classifier
Support Vector Machines, a technique derived from statis-
tical learning theory, is used to classify points by assigning
them to one of two disjoint half spaces [9]. So, SVM
performs mainly a (binary) 2-class classification. For linearly
separable data, SVM obtains the hyperplane which maxi-
mizes the margin (distance) between the training samples
and the class boundary. For non linearly separable cases,
samples are mapped to a high dimensional space where
such a separating hyperplane can be found. The assignment
is carried out by means of a mechanism called the kernel
function.
SVM is widely used in the domain of cancer studies,
protein identification and specially in Microarray data [6],
[12], [19]. Unfortunately, in many bioinformatics problems
the number of features is significantly larger than the number
of samples. For this reason, tools for decreasing the number
of features in order to improve the classification or to help
to identify interesting features (genes) in noisy environments
are necessary. In addition, SVM can treat data with a large
number of genes, but it has been shown that its perfor-
mance is increased by reducing the number of genes [20].
The hybrid PSO and hybrid GA approaches next proposed
contribute notably in this sense.
C. The Hybrid PSOSVM Approach
In order to offer a basic idea of the operation of our
PSOSVM approach, in Figure 1, we can observe a sim-
ple scheme of how features are extracted from the initial
microarray dataset and how the resulted subset is evaluated.
In a first phase, the metaheuristic algorithm involved, PSO
in this case, provides a binary encoded particle1 where each
bit2 represents a gene. If a bit is 1, it means that this gene
is kept in the subset and 0 indicates that the gene is not
included in the subset. Therefore, the particle length is equal
to the number of genes in the initial microarray dataset.
The original PSO was initially developed for continuous
optimization problems. However, lots of practical enginee-
ring problems are formulated as combinatorial optimization
problems and specifically as binary decisions. Several binary
versions of PSO can be found in present literature [21], [22].
Nevertheless, these versions consist on ad hoc adaptations
from the original PSO and therefore their performances are
usually improvable.
With the aim of facing the gene selection problem, an
innovative version of PSO, based on the geometric frame-
work presented in [14], has been developed in this work.
This version, called Geometric Particle Swarm Optimiza-
tion (GPSO), enables to us to generalize PSO to virtually
any solution representation in a natural and straightforward
way. This property was demonstrated for the cases of Eu-
clidean, Manhattan and Hamming spaces in the referenced
work. Even a recently appeared work [23], uses the GPSO
for solving the Sudoku Puzzle by means of permutations
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Fig. 1. A simple scheme of how features (genes) are selected out from the original microarray dataset using a particle with binary encoding. In a second
phase, the resulted subset is evaluated by means of a SVM classifier and 10-fold cross validation to obtain the fitness value (accuracy) of such particle.
representation. Since the gene selection problem has been
represented by binary way, specific operators for Hamming
space were used in the PSO described here.
D. Geometric Particle Swarm Optimization
In this version, the location of each particle i is represented
as vector xi = 〈xi1, xi2, ..., xiN 〉 taking each bit xij (with
j in {1, N}) binary values 0 or 1. The key issue of the
GPSO is the concept of particle movement. In this approach,
instead of the notion of velocity added to the position, a
three-parent mask-based crossover (3PMBCX) operator is
applied to each particle in order to “move” it. According to
the definition of 3PMBCX [14], given three parents a, b and
c in {0, 1}n, generate randomly a crossover mask of length n
with symbols from the alphabet {a, b, c}. Build the offspring
filling each element with the bit from the parent appearing
in the crossover mask at the position.
The pseudocode of the GPSO algorithm for Hamming
spaces is illustrated in Algorithm 1. For a given particle i,
three parents take part in the 3PMBCX operator (line 13): the
current position xi, the social best position gi and the histori-
cal best position found hi (of this particle). The weight values
w1, w2 and w3 indicate for each element in the crossover
mask the probability of having values from the parents xi,
gi or hi respectively. These weight values associated to each
parent represent the inertia value of the current position (w1),
the social influence of the global/local best position (w2) and
the individual influence of the historical best position found
(w3). A constriction of the geometric crossover forces w1,
w2 and w3 to be non-negative and add up to one.
In summary, the GPSO developed in this study oper-
ates as follows: In a first phase of the pseudocode, the
initialization of particles are carried out by means of the
SwarmInitialization() function (Line 1). This special
initialization method (used also in our GA approach) was
adapted to gene selection as follows. The swarm (population)
was divided into four subsets of particles (chromosomes)
initialized in different ways depending on the number of
features in each particle. That is, 10% of particles were
initialized with N (prefixed value) selected genes (1s) located
randomly. Another 20% of particles were initialized with 2N
genes, 30% with 3N genes and finally, the rest of particles
(40%) were initialized randomly and 50% of the genes were
turned on. In these experiments N will be equal to 4. In
Algorithm 1 Pseudocode of the GPSO for Hamming space.
1: S ← SwarmInitialization()
2: while not stop condition do
3: for each particle xi of the swarm S do
4: evaluate(xi)
5: if fitness(xi) is better than fitness(hi) then
6: hi ← xi
7: end if
8: if fitness(hi) is better than fitness(gi) then
9: gi ← hi
10: end if
11: end for
12: for each particle xi of the swarm S do
13: xi ← 3PMBCX((xi, w1), (gi, w2), (hi, w3))
14: mutate(xi)
15: end for
16: end while
17: Output: best solution found
a second phase, after the evaluation of particles (line 4),
historical and social position are updated (lines 5 to 10).
Finally, particles are “moved” by means of the 3PMBCX
operator (line 13). In addition, with a probability of 10%,
a simple bit-mutation operator (line 14) is applied in order
to avoid the early convergence. This process is repeated
until reach the stop condition fixed to a certain number of
evolutions.
E. Evaluation Function
Since the position of a particle xi represents a gene subset,
the evaluation of each particle is carried out by means of the
SVM classifier to assess the quality of the represented gene
subset. The fitness of a particle xi is calculated applying a 10-
fold Cross Validation (10FCV) method to calculate the rate of
correct classification (accuracy) of a SVM trained with this
gene subset. In 10FCV, the data set is divided into 10 subsets.
Each time, one of the 10 subsets is used as the test set and
the other 9 subsets are put together to form the training set.
Then the average error across all 10 trials is computed. The
complete fitness function is described in Equation 4.
fitness(x) = α · (100/accuracy) + β ·#features, (4)
where α and β are weight values set to 0.75 and 0.25
respectively in order to control that the accuracy value
takes priority over the subset size, since high accuracies are
preferred when guiding the search process. The objective
here consists of maximizing the accuracy and minimizing
the number of genes (#features). For convenience (only
minimization of fitness) the first factor is presented as
(100/accuracy).
III. DATA SETS
Instances used in this study consists of six well-
known datasets issued of microarray experiments, ALL-
AML Leuke-mia dataset, Breast cancer dataset, Colon tumor
dataset, Ovarian cancer dataset, Prostate cancer dataset, and
Lung cancer dataset. All of them were taken from the public
Kent Ridge Bio-medical Data Repository with url http://
sdmc.lit.org.sg/GEDatasets/Datasets.html.
◦ The ALL-AML Leukemia dataset consists of 72 mi-
croarray experiments with 7129 gene expression le-
vels. Two classes for distinguishing: Acute Myeloid
Leukemia (AML) and Acute Lymphoblastic Leukemia
(ALL). The complete dataset contains 25 AML and 47
ALL samples.
◦ The Breast cancer dataset consists of 97 experiments
with 24481 gene expression levels. Patients studied
show two classes of diagnosis called relapse with 46
patients and non-relapse with 51 ones.
◦ The Colon tumor dataset consists of 62 microarray
experiments collected from colon-cancer patients with
2000 gene expression levels. Among them, 40 tumor
biopsies are from tumors and 22 (normal) biopsies are
from healthy parts of the colons of the same patients.
◦ The Lung cancer dataset involves 181 microarray ex-
periments with 12533 gene expression levels. Classifi-
cation occurs between Malignant Pleural Mesothelioma
(MPM) and Adenocarcinoma (ADCA) of the lung. In
tissue samples there are 31 MPM and 150 ADCA.
◦ The Ovarian cancer dataset consists of 253 microarray
experiments with 15154 gene expression levels. The
goal of this experiment is to identify proteomic patterns
in serum that distinguish cancer from non-cancer scenar-
ios. The dataset includes 162 (of 253) ovarian cancers
and 91 normal ones.
◦ The Prostate cancer dataset involves 136 microarray
experiments with 12600 gene expression levels. Two
classes must be differentiated: tumor with 77 (52+ 25)
samples and non-tumor with 59 (50+9) samples.
IV. EXPERIMENTAL RESULTS AND COMPARISONS
For our PSOSVM approach, the PSO was imple-
mented in C++ following the skeleton architecture of the
MALLBA [24] library. For the GASVM approach the GA
was implemented in C++ using the ParadisEO [25] Frame-
work. The GA implements a generational evolution strategy
(offspring replacement with elitism) and uses the follow-
ing operators: deterministic tournament selection, SSOCF
crossover, and uniform mutation. The SVM classifier used
in both approaches is based on the LIBSVM [26] library.
For the SVM confi-guration, the same parameters were used
in PSO and GA algorithms and the Kernel function was
configured as Linear. The fitness function used in GASVM
is the same one (described in Section II) as in PSOSVM .
All experiments were carried out using a PC with Linux
O.S (Suse 9.0 with kernel 2.4.19) and a Pentium IV 2.8GHz
processor, with 512MB of RAM. PSOSVM and GASVM
algorithms on six cancer related microarray datasets were
independent executed 10 times over each dataset, in order to
have statistically meaningful conclusions as both algorithms
are stochastics.
A. Parameters Settings
The parameters used in our PSO and GA algorithms
are shown in Table I. These parameter were selected after
several test evaluations of each algorithm and dataset instance
until reach the best configuration in terms of the quality of
solutions and the computational effort.
TABLE I
PSO AND GA PARAMETERS FOR GENE SUBSET SELECTION AND
CLASSIFICATION
PSO GA
Parameter Value Parameter Value
Swarm size 40 Population size 40
Number of generations 100 Number of generations 100
Neighborhood size 20 Probability of crossover 0.9
Probability of mutation 0.1 Probability of mutation 0.1
(w1, w2, w3) (0.33, 0.33, 0.34) - -
B. Discussion and Analysis
Several observations can made based on the above expe-
riments, so we tackle the analysis of results focusing on the
performance and robustness of our algorithms, as well as
the quality of the obtained solutions providing a biological
description of most significant ones.
1) Performance Analysis: From the point of view of
the performance, both algorithms obtain in a few iterations
acceptable results in gene selection, providing reduced sub-
sets with high classification rates. However, the behavior
is slightly different. Figure 2 shows a graphical evolution,
in terms of the average of the fitness value, of a typical
execution of PSOSVM and GASVM . It is noticeable that in
few iterations (4 or 5) the average of fitness decrease quickly
and then stop in similar solutions. The large diversity of
solutions provided in the initialization method (Section II-B)
provokes fast of good solutions and the early convergence
of both methods. Although the GASVM generally obtains
lower average than PSOSVM , whose solutions have in turn
higher diversity.
Results for all the datasets are shown in Table II. Columns
2 and 3 contain the average of the best solutions obtained
in 10 independent executions of PSOSVM and GASVM
respectively. Six state of the art methods from literature are
presented in columns 4 to 10 in order to show how our
proposals actually push forward the research in this area.
Cells in - haven’t values to our knowledge. Standard criteria
are used to compare the results: the classification accuracy
in terms of the rate of correct classification (first value in
every table cell) and the number of selected genes (the value
in parenthesis).
TABLE II
COMPARISON OF RELEVANT WORKS ON CANCER CLASSIFICATION WITH PROPOSED MODELS GASVM AND PSOSVM . IN BOLD WE MARK THE
MOST ACCURATE RESULTS. CELLS WITHOUT KNOWN VALUE (TO US) ARE MARKED WITH - CHARACTER
Dataset PSOSVM GASVM [5] [6] [12] [27] [28] [29] [30]
Luekemia 97.38(3) 97.27(4) - 100(2) 100(25) 100(4) 87.55(4) - -
Breast 86.35(4) 95.86(4) - - - - 79.38(67) - -
Colon 100(2) 100(3) 94.12(37) 98.0(4) 99.41(10) 97.0(7) 93.55(4) 85.48(-) 94.00(4)
Lung 99.00(4) 99.49(4) - - - - 98.34(6) - -
Ovarian 99.44(4) 98.83(4) - - - - - 99.21(75) -
Prostate 98.66(4) 98.65(4) 88.88(20) - - - - - -
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Fig. 2. Evolution of the average fitness (AVG Fitness) in a typical execution
of PSOSVM and GASVM approaches using the Leukemia dataset.
In this comparison, we can observe that all solutions
provided by our PSOSVM and GASVM algorithms present
a classification rate higher than 86%, and subsets with
four and less than four selected genes are common. We
outperform all the existing results (to our knowledge) but
one case [6] presents a smaller subset of 2 genes. We suspect
that the initialization method used in our work helps the
performance of the algorithms significantly, finding small
subsets with a high classification accuracy. PSO with SVM
algorithm was also used in [30] (PSO/SVM from now on),
although showing several differences with respect to our
PSOSVM . In the first place, in PSO/SVM the binary values
of each particle are chosen at each iteration by means of a
decision function based on threshold parameters, whereas in
PSOSVM , binary particles evolve following a completely
different mechanism, that is, 3PMBCX crossover and muta-
tion operators (Subsection II-D). In second place, during the
evaluation phase, a leave-half-out cross-validation method
was used in PSO/SVM whereas the PSOSVM validates the
selected subsets by means of 10 k fold cross-validation.
If we compare our GPSO and GA metaheuristics com-
bined with SVM similar results are found. In general, the GA
approach obtain better best solutions (Hits) although the best
classification was provided by GPSOSVM for the Colon
tumor dataset (100% accuracy and 2 genes in Table IV).
From the point of view of the accuracy average in all
independent runs, the GPSO obtain a better performance
although the difference with regard to the GA (as shows
Fig. 3) is insignificant.
2) Algorithm Robustness: One of the most important
criteria in evaluating any proposed algorithm is the quality
of the algorithm and its ability to generate similar (identical)
outcomes when executed several times. This factor is very
important for metaheuristics which is the case in this work.
To examine the robustness of the two proposed approaches,
in some instances, in all ten runs both algorithms manages
to find the same answer or similar ones (not identical).
However, it is worthwhile mentioning that the total accuracy
and number of selected features in all the cases did not
deviate from each other by more than 5.5. Table III shows the
result of running the GASVM and PSOSVM algorithms in
terms of statistical results, reporting the Best solution found,
Mean and Standard Deviation of ten independent runs.
TABLE III
COMPARISON IN TERMS OF STATISTICAL RESULTS OF THE GASVM
AND PSOSVM APPROACHES. THE Best SOLUTION FOUND, Mean AND
Standard Deviation OF 10 INDEPENDENT RUNS WERE REPORTED
Dataset PSOSVM GASVMBest Mean Std Dev. Best Mean Std Dev.
Leukemia 100(3) 97.38(3) 3.80 100(4) 97.27(4) 3.82
Breast 90.72(4) 86.35(4) 4.11 100(4) 95.86(4) 5.33
Colon 100(2) 100(2) 0.0000 100(3) 100(3) 0.0000
Lung 99.44(4) 99.00(4) 0.50 100(4) 99.49(4) 0.41
Ovarian 100(4) 99.44(4) 0.38 100(4) 98.83(4) 3.18
Prostate 100(4) 98.66(4) 1.14 100(4) 98.65(4) 3.24
3) Brief Biological Analysis of Selected Genes: Finally, a
summary of the best subsets of genes found for each dataset
is shown in Table IV. All subset of genes which reported
close to 100% test accuracy and the minimum number of
genes. It is remarkable that apparently (to our knowledge)
several discovered genes that has not been seen in any past
studies. In this sense, we can provide a brief biological
description of some of the most frequently obtained genes
since they are currently used in the design of drugs and
cancers treatment. Some of which are listed below:
• Gene L12052 at is “CAMP phosphodiesterase mRNA,
3’ end” which is used in drugs like Anagrelide or
Milrinone. Specifically the Anagrelide is used for the
treatment of essential thrombocytosis, and it was proved
to be effective in treating patients with certain kinds of
leukemia such as chronic myeloid leukemia [31]. This
gene belongs to a set of 3 genes (reported from leukemia
dataset in Table IV) with 100% accuracy selected by the
PSOSVM .
• Gene AB022847 is a “Solute carrier family 6 (neu-
TABLE IV
SUBSETS OF GENES REPORTED WITH 100% TEST ACCURACY
Dataset PSOSVM GASVM
Leukemia 100(3) U39226 at, L12052 at, 100(4) Z26634 at, HG870-HT870 atX99101 at X52005 at, L02840 at
Breast 90.72(4) NM 012269, NM 002850 100(4) NM 005014, AF060168AL162032, AB022847 NM 021176, NM 013242
Colon 100(2) U29092, M55543 100(3) M90684, M94132X62025
Lung 99.44(4) 31820 at, 33389 at 100(4) 31573 at, 33226 at39057 at, 40772 at 36245 at, 37076 at
Ovarian 100(4) MZ49.784115, MZ3546.2884 100(4) MZ420.40671, MZ825.16557MZ4362.0866, MZ9159.3641 MZ1024.6857, MZ1166.0749
Prostate 100(4) 35106 at, 35869 at 100(4) 41447 at, 34299 at36754 at, 37107 at 39556 at, 39813 s at
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Fig. 3. Accuracy obtained by PSOSVM and GASVM in each independent run. Legends specify the datasets with the number of features in parenthesis.
rotransmitter transporter, noradrenalin), member 2” lo-
cated in plasma membrane. Current drugs like Radax-
afine, Amphetamine or Venlafaxine are associated with
this gene. Specifically, Venlafaxine is a prescription
antidepressant first introduced by Wyeth in 1993. It
is specifically used in management of hot flashes in
survivors of breast cancer [32]. This gene belongs to a
set of 3 genes (reported from breast dataset in Table IV)
with 95.8763% accuracy selected by the PSOSVM .
• Gene 36245 at is “5-hydroxytryptamine (serotonin) re-
ceptor 2B” located in human plasma membrane. There
are several drugs where this gene is used like Risperi-
done, Blonanserin and Mirtazapine. Some studies con-
sider Mirtazapine as the first-choice agent for anxiety
and depression after lung transplantation. This gene
belongs to a set of 4 genes (reported from lung dataset in
Table IV) with 100% accuracy selected by the GASVM .
V. CONCLUSIONS AND FUTURE WORK
In this work, two hybrid techniques for gene selection
and classification of high dimensional DNA Microarray data
were presented and compared. These techniques are based
on different metaheuristic algorithms such as GPSO and GA
used for feature selection using the SVM classifier to identify
potentially good gene subsets. Specifically, the Geometric
PSO algorithm for Hamming space was used to solve a real
problem (gene selection in this case) for the first time (to
our knowledge). In addition, genes selected are validated by
an accurate 10-fold cross validation method to improve the
actual classification.
Both approaches (PSOSVM and GASVM ) were experi-
mentally assessed on six well-known cancer datasets disco-
vering new and challenging results, and identifying specific
genes that our work suggests as significant ones. In this
sense, comparisons with several state of art methods show
competitive results according to standard evaluation. Results
of 100% classification rate and few genes per subset (3 and
4) are obtained in most of our executions. The use of an
adapted initialization method has shown a great influence on
the performance of proposed algorithms, since it introduces
an early set of acceptable solutions in their evolution process.
Continuing the line of this work, we are interested in deve-
loping and testing several combinations of other metaheuris-
tics with classification methods in order to discover new and
better subsets of genes using specific Microarray datasets. In
this sense, the utilization of multiobjective approaches could
contribute notably in gene subset selection.
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